Characteristics of Cerebral Microbleeds

Category: Papers

Related Topics: cerebral microbleeds, sT2W, T1W, T1WE, T2*W

Author(s): Juyoun Lee , Eun Hee Sohn , Eungseok Oh , Ae Young Lee
Journal: Dementia and Neurocognitive Disorders
Published: 2018
Read Full Paper: https://pubmed.ncbi.nlm.nih.gov/30906396/

Abstract

Cerebral microbleeds (CMBs) are increasingly recognized neuroimaging findings, occurring with cerebrovascular disease, dementia, and aging. CMBs are associated with subsequent hemorrhagic and ischemic stroke, and also with an increased risk of cognitive deterioration and dementia. They occur in the setting of impaired small vessel integrity due to hypertension or cerebral amyloid angiopathy. This review summarizes the concepts, cause or risk factors, histopathological mechanisms, and clinical consequences of CMBs.

Read Full Paper

New & Related

All Resources

A Comparison of Time-Efficient MR Techniques and Critical Details to Consider

So....You want to shorten the time of your MRI protocols, while also preserving the quality of the images? SpinTech MRI has the solution for you. The following abstract, led by members of Yale School of Medicine - Radiology and Biomedical Imaging, gives a structured...

Editorial: Quantitative Susceptibility Mapping in Neurodegeneration

The purpose of this study was to evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter (DGM) of the human brain using subjects from multiple sites; and to establish a susceptibility baseline as a function of age for each DGM structure using both a global and regional iron analysis.

Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study

The purpose of this study was to evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter (DGM) of the human brain using subjects from multiple sites; and to establish a susceptibility baseline as a function of age for each DGM structure using both a global and regional iron analysis.